Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

WestGene to Start US Trials of EB Virus-Related mRNA Therapeutic Cancer Vaccine

publication date: May 10, 2024

Chengdu WestGene Biopharma was approved to start US trials of its Epstein-Barr (EB) virus-related mRNA therapeutic cancer vaccine, the first mRNA candidate approved to start trials for the indication. The EB virus is correlated with more than ten malignancies. WestGene says WGc-043, its lead candidate, offers promising efficacy, low toxicity, broad applicability and efficient scalability at a cost-effective price. WGc-043 has already completed investigator-initiated trials in nasopharyngeal carcinoma and natural killer T-cell lymphoma, showing better safety and efficacy than other publicly available mRNA therapeutic cancer vaccines. More details.....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here